Comparison 30. Withdrawals six months: etanercept vs. disease‐modifying anti‐rheumatic drug (DMARD).

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Total	1	238	Risk Ratio (M‐H, Fixed, 95% CI)	1.44 [0.72, 2.88]
2 Lack of efficacy	1		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
2.1 Etanercept 25 mg SC twice weekly	1	153	Risk Ratio (M‐H, Fixed, 95% CI)	0.04 [0.01, 0.30]
3 Adverse event	1		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
3.1 Etanercept 25 mg SC twice weekly	1	153	Risk Ratio (M‐H, Fixed, 95% CI)	0.97 [0.25, 3.72]